Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Schizophrenia Research
|
July 16, 2011
Theory of Mind in patients at clinical high risk for psychosis
Arielle D Stanford, Julie Messinger, Dolores Malaspina, et al.
Biological Psychiatry
|
January 9, 2007
Revisiting the backward masking deficit in schizophrenia: individual differences in performance and modeling with transcranial magnetic stimulation
Bruce Luber, Arielle D Stanford, Dolores Malaspina, et al.
CNS Spectrums
|
June 27, 2018
Switching stable patients with schizophrenia from their oral antipsychotics to aripiprazole lauroxil: a post hoc safety analysis of the initial 12-week crossover period
Peter J Weiden, Yangchun Du, Chih-Chin Liu, et al.
Neuropsychiatric Disease and Treatment
|
May 2, 2019
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)
John M Zajecka, Arielle D Stanford, Asli Memisoglu, et al.
Psychiatry Research
|
February 26, 2019
Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study
Christoph U Correll, Arielle D Stanford, Amy Claxton, et al.
The International Journal of Neuropsychopharmacology
|
February 5, 2008
rTMS strategies for the study and treatment of schizophrenia: a review
Arielle D Stanford, Zafar Sharif, Cheryl Corcoran, et al.
Schizophrenia Research
|
March 24, 2009
Family history of affective illness in schizophrenia patients: symptoms and cognition
Deidre Anglin, Arielle D Stanford, Jill M Harkavy-Friedman, et al.
The Journal of ECT
|
October 23, 2010
High-frequency prefrontal repetitive transcranial magnetic stimulation for the negative symptoms of schizophrenia: a case series
Arielle D Stanford, Cheryl Corcoran, Peter Bulow, et al.
CNS Spectrums
|
August 16, 2018
Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
Henry A Nasrallah, Ralph Aquila, Yangchun Du, et al.
Neuropsychologia
|
September 18, 2013
Single pulse TMS differentially modulates reward behavior
Arielle D Stanford, Bruce Luber, Layla Unger, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Schizophrenia Research
|
July 16, 2011
Theory of Mind in patients at clinical high risk for psychosis
Arielle D Stanford, Julie Messinger, Dolores Malaspina, et al.
Biological Psychiatry
|
January 9, 2007
Revisiting the backward masking deficit in schizophrenia: individual differences in performance and modeling with transcranial magnetic stimulation
Bruce Luber, Arielle D Stanford, Dolores Malaspina, et al.
CNS Spectrums
|
June 27, 2018
Switching stable patients with schizophrenia from their oral antipsychotics to aripiprazole lauroxil: a post hoc safety analysis of the initial 12-week crossover period
Peter J Weiden, Yangchun Du, Chih-Chin Liu, et al.
Neuropsychiatric Disease and Treatment
|
May 2, 2019
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)
John M Zajecka, Arielle D Stanford, Asli Memisoglu, et al.
Psychiatry Research
|
February 26, 2019
Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study
Christoph U Correll, Arielle D Stanford, Amy Claxton, et al.
The International Journal of Neuropsychopharmacology
|
February 5, 2008
rTMS strategies for the study and treatment of schizophrenia: a review
Arielle D Stanford, Zafar Sharif, Cheryl Corcoran, et al.
Schizophrenia Research
|
March 24, 2009
Family history of affective illness in schizophrenia patients: symptoms and cognition
Deidre Anglin, Arielle D Stanford, Jill M Harkavy-Friedman, et al.
The Journal of ECT
|
October 23, 2010
High-frequency prefrontal repetitive transcranial magnetic stimulation for the negative symptoms of schizophrenia: a case series
Arielle D Stanford, Cheryl Corcoran, Peter Bulow, et al.
CNS Spectrums
|
August 16, 2018
Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
Henry A Nasrallah, Ralph Aquila, Yangchun Du, et al.
Neuropsychologia
|
September 18, 2013
Single pulse TMS differentially modulates reward behavior
Arielle D Stanford, Bruce Luber, Layla Unger, et al.
Page
of 3